Home/Filings/4/0001104659-22-120833
4//SEC Filing

Toselli Richard M. 4

Accession 0001104659-22-120833

CIK 0001292519other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 5:04 PM ET

Size

5.6 KB

Accession

0001104659-22-120833

Insider Transaction Report

Form 4
Period: 2022-11-17
Toselli Richard M.
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-11-17+61,00061,000 total
    Exercise: $2.50Exp: 2032-11-16Common Stock (61,000 underlying)
Footnotes (1)
  • [F1]The option was granted on November 17, 2022. The shares underlying the option vest over two years, with 50% of the shares vesting on November 17, 2023 and the remaining shares vesting on November 17, 2024.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeother

Related Parties

1
  • filerCIK 0001710549

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:04 PM ET
Size
5.6 KB